SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!
pipi
Lv3
220 积分
2023-03-22 加入
最近求助
最近应助
互助留言
TAK-137, an AMPA-R potentiator with little agonistic effect, has a wide therapeutic window
7天前
已关闭
A trispecific antibody targeting HER2 and T cells inhibits breast cancer growth via CD4 cells
11天前
已完结
TAK-653, an AMPA receptor potentiator with minimal agonistic activity, produces an antidepressant-like effect with a favorable safety profile in rats
11天前
已完结
Efficacy and safety of luspatercept versus epoetin alfa in erythropoiesis-stimulating agent-naive, transfusion-dependent, lower-risk myelodysplastic syndromes (COMMANDS): interim analysis of a phase 3, open-label, randomised controlled trial
13天前
已完结
Patterns of lower risk myelodysplastic syndrome progression: factors predicting progression to high-risk myelodysplastic syndrome and acute myeloid leukemia
13天前
已完结
[The results of the Russian multicenter open observational non-comparative study on the efficacy and safety of valdoxan (agomelatin) in the treatment of patients with major depressive disorder and insomnia (the VIVALDI study)]
25天前
已关闭
The Comparative Effectiveness and Safety of Insomnia Drugs: A Systematic Review and Network Meta-Analysis of 153 Randomized Trials
27天前
已完结
Sleep medicine in China: current clinical practice
27天前
已关闭
A covalent fragment-based strategy targeting a novel cysteine to inhibit activity of mutant EGFR kinase
1个月前
已完结
Discovery of a novel potent EGFR inhibitor against EGFR activating mutations and on-target resistance in NSCLC
1个月前
已完结
没有进行任何应助
不需要【积分已退回】
7天前
不需要【积分已退回】
27天前
doi填写错误【积分已退回】
1个月前
doi错误
1个月前
不需要【积分已退回】
3个月前
不相应【积分已退回】
6个月前
不需要了【积分已退回】
6个月前
文章错误
6个月前
已经有了【积分已退回】
10个月前
其它途径找到了【积分已退回】
1年前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论